Press coverage about Inovalon (NASDAQ:INOV) has been trending somewhat positive on Friday, Accern Sentiment reports. The research group rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Inovalon earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media stories about the technology company an impact score of 45.5475091152649 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Several equities research analysts recently issued reports on INOV shares. ValuEngine upgraded shares of Inovalon from a “sell” rating to a “hold” rating in a research report on Wednesday, September 6th. Morgan Stanley upgraded shares of Inovalon from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $9.00 to $14.00 in a research report on Tuesday, September 12th. KeyCorp restated a “hold” rating on shares of Inovalon in a research report on Tuesday, September 12th. TheStreet upgraded shares of Inovalon from a “d+” rating to a “c-” rating in a research report on Thursday, October 5th. Finally, Zacks Investment Research cut shares of Inovalon from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. Three analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $12.00.

Shares of Inovalon (INOV) opened at $14.70 on Friday. Inovalon has a 12-month low of $8.80 and a 12-month high of $17.80. The stock has a market cap of $2,180.00 and a PE ratio of 70.95. The company has a debt-to-equity ratio of 0.31, a quick ratio of 5.62 and a current ratio of 5.62.

Inovalon (NASDAQ:INOV) last released its quarterly earnings data on Wednesday, November 1st. The technology company reported $0.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.08 by $0.01. Inovalon had a net margin of 4.07% and a return on equity of 4.63%. The firm had revenue of $115.90 million during the quarter, compared to analysts’ expectations of $114.79 million. During the same period last year, the business earned $0.10 earnings per share. Inovalon’s revenue was up 10.4% compared to the same quarter last year. analysts predict that Inovalon will post 0.24 EPS for the current year.

In other Inovalon news, President Robert A. Wychulis sold 85,828 shares of Inovalon stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $15.54, for a total transaction of $1,333,767.12. Following the completion of the sale, the president now directly owns 466,286 shares in the company, valued at $7,246,084.44. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Shauna L. Vernal sold 5,908 shares of Inovalon stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $16.01, for a total transaction of $94,587.08. Following the sale, the insider now owns 47,309 shares of the company’s stock, valued at $757,417.09. The disclosure for this sale can be found here. 48.28% of the stock is owned by company insiders.

WARNING: “Inovalon (INOV) Earns Media Impact Score of 0.03” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://www.watchlistnews.com/inovalon-inov-earns-media-impact-score-of-0-03/1764633.html.

About Inovalon

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Insider Buying and Selling by Quarter for Inovalon (NASDAQ:INOV)

Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with Analyst Ratings Network's FREE daily email newsletter.